Results 231 to 240 of about 48,196 (249)

Vasoactive Intestinal Peptide (VIP)

2003
Bahri˙ Karaçay, M. Sue O'Dorisio
openaire   +1 more source

Catalytic Autoantibodies to Vasoactive Intestinal Peptide

Chest, 1995
S, Paul, Q S, Gao, H, Huang, M, Sun, A, Thompson, S, Rennard, D, Landers   +6 more
openaire   +2 more sources

State of the science on prevention and screening to reduce melanoma incidence and mortality: The time is now

Ca-A Cancer Journal for Clinicians, 2016
Susan M Swetter
exaly  

Cancer screening in the United States, 2016: A review of current American Cancer Society guidelines and current issues in cancer screening

Ca-A Cancer Journal for Clinicians, 2016
Robert A Smith, Stacey A Fedewa, Joannie Lortet-Tieulent   +2 more
exaly  

Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer‐related cognitive impairment in adults

Ca-A Cancer Journal for Clinicians, 2015
Jeffrey S Wefel, Shelli R Kesler
exaly  

Cancer screening, prevention, and treatment in people with mental illness

Ca-A Cancer Journal for Clinicians, 2016
Ana Stefancic, Amy T Cunningham, Richard C Wender   +2 more
exaly  

Cancer screening in the United States, 2014: A review of current American Cancer Society guidelines and current issues in cancer screening

Ca-A Cancer Journal for Clinicians, 2014
Robert A Smith
exaly  

Breast cancer statistics, 2015: Convergence of incidence rates between black and white women

Ca-A Cancer Journal for Clinicians, 2016
Carol E Desantis, Ann Goding Sauer Msph, Robert A Smith   +2 more
exaly  

Cancer screening in the United States, 2015: A review of current American Cancer Society guidelines and current issues in cancer screening

Ca-A Cancer Journal for Clinicians, 2015
Robert A Smith
exaly  

The vasoactive intestinal peptide (VIP)

Bioorganic Chemistry, 1974
Miklos Bodanszky, Cynthia Yang Lin, Sami I. Said   +2 more
openaire   +1 more source